Status:
TERMINATED
A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19 Infection
Lead Sponsor:
University of Nebraska
Conditions:
Covid19
Eligibility:
All Genders
19+ years
Brief Summary
The corona virus disease (COVID) pandemic has highlighted the importance of rapid, readily available screeners and diagnostics to identify infected individuals. Recent studies have demonstrated that p...
Detailed Description
Purpose. This study will assess the feasibility of using an electronic nose to detect signals indicating infection with severe acute respiratory distress syndrome corona virus-2 (SARS-CoV-2). Five dif...
Eligibility Criteria
Inclusion
- °Admission for definite or suspected SARS-CoV-2 infection with mild to moderate symptoms and clinical features.
- If insufficient numbers of suspected cases who test negative, individuals admitted with other respiratory problems: COPD exacerbation, viral pneumonia, congestive heart failure who test negative for SARS-CoV-2 will be eligible as controls.
- Able to give informed consent.
- Access to a smartphone capable of downloading the study app and of collecting and transmitting study data.
- Ability to comply with study procedures.
- Ability to self-deploy the study devices and collect study data.
Exclusion
- Inability to give informed consent.
- Allergic history to components of study devices,
- Inability to participate in study procedures.
- Severe disease or admission to a critical care unit.
Key Trial Info
Start Date :
April 4 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 7 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04807075
Start Date
April 4 2021
End Date
June 7 2022
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198